Back

Sacubitril/valsartan and SGLT2 inhibitors as novel treatment strategies

23 May 2022 (09:06 - 09:18)
Organised by:
Congress Presentation Part of: Solving the puzzle of HFpEF: pearls for clinical management Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Marco Metra

IRCCS San Raffaele Scientific Institute, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
New insights into the multifaceted mechanisms and clinical implications.
Professor B. Pieske (Rostock, DE)
Slides Video
Presentation thumbnail
The spectrum of phenotypes: diagnostic, therapeutic, and prognostic relevance.
Professor M. Senni (Bergamo, IT)
Slides Video
Presentation thumbnail
The conundrum of comorbidities and their role in management.
Professor G. Savarese (Stockholm, SE)
Slides Video
Presentation thumbnail
Solving the puzzle of HFpEF: pearls for clinical management - discussion.
Video

Access the full session

Session thumbnail
Solving the puzzle of HFpEF: pearls for clinical management
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 09:06 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitors: evidence across the spectrum of heart failure.
26 August 2022
thumbnail
Congress Presentation
How should we treat HFpEF?
28 August 2023
thumbnail
Congress Presentation
SGLT2i is indicated for all HFpEF patients - con.
23 May 2022
thumbnail
Congress Presentation
SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources